What Should be the Anesthesia Method in Endobronchial Coil Treatment

This prospective, randomize study was conducted in a university hospital. Bronchoscopic lung volume reduction (BLVR) coil treatment has recently been introduced into clinical practice as an alternative for patients chronic obstructive pulmonary disease (COPD) with severe refractory heterorogenous emphysema to conventional medical treatment. Thirty two patients diagnosed with (COPD) with severe refractory heterorogenous emphysema undergoing BLVR coil treatment were included in the study. Seventeen procedure were performed under general anesthesia and fifteen procedure were performed under deep sedation-analgesia. in the general anesthesia group peak pressure, air leakage and end-tidal carbon dioxide were recorded. In the both groups pulse oximeter, transcutaneous carbondioxide, recovery time, bronchospasm, laryngospasm, pneumothorax, massive bleeding were recorded.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coil Treatment Deep Sedation

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bozok University

Yozgat, Eyalet/Yerleşke, 66100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients diagnosed with COPD with undergoing BLVR coil treatment.

Exclusion criteria

patients who refuse to participate in the study

Treatment and study plan

Method

Other

to compare the use of general anesthesia and deep sedation

Primary outcomes

recovery time measurement

Time frame: 2 hours

to compare the recovery time in both groups
complication rate

Time frame: 2 hours

to compare the complication rate in both groups

Sponsors and collaborators

Lead sponsor

TC Erciyes University

Other

Collaborators

Bozok University

Registry information

Official study title

Comparison of General Anesthesia and Deep Sedation in Enbronchial Coil Treatment

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Aug 29, 2018
Registry last updated: Aug 31, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed